Clicky

Galera Therapeutics, Inc.(GRTX)

Description: Galera Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.


Keywords: Medicine Biotechnology Cancer Radiation Radiation Therapy DSL Fibrosis Mucositis Treatment Of Fibrosis

Home Page: www.galeratx.com

GRTX Technical Analysis

2 West Liberty Boulevard
Malvern, PA 19355
United States
Phone: 610 725 1500


Officers

Name Title
Dr. J. Mel Sorensen M.D. CEO, Pres & Director
Mr. Christopher Degnan Chief Financial Officer
Mr. Mark J. Bachleda M.B.A., Pharm.D. Chief Commercial Officer
Dr. Robert A. Beardsley M.B.A., Ph.D. Co-Founder & COO
Dr. Dennis P. Riley Ph.D. Chief Scientific Officer, Emeritus
Ms. Jennifer Evans Stacey Esq. Chief Legal & Compliance Officer and Sec.
Dr. Jon T. Holmlund M.D. Exec. Officer
Ms. Andie Collier Sr. VP of Regulatory Affairs
Ms. Judy Schnyder Sr. VP of Clinical Operations & Data Management
Dr. Eugene P. Kennedy F.A.C.S., FACS, M.D. Chief Medical Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

GIC Sector: Health Care
GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
GIC Industry: Biotechnology
GIC Sub-Industry:
Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 29.3902
Price-to-Sales TTM: 0
IPO Date: 2019-11-07
Fiscal Year End: December
Full Time Employees: 30
Back to stocks